NCT04904588 2026-03-18ACCESSCenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting300 enrolled
NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT03277729 2026-01-05A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasFred Hutchinson Cancer CenterPhase 1/2 Active not recruiting53 enrolled 11 charts